Glycoursodeoxycholic acid regulates peritoneal monocytic myeloid-derived suppressor cells to alleviate systemic inflammation in decompensated cirrhosis
{{output}}
Objectives: Decompensated cirrhosis represents the end-stage of chronic liver diseases and is characterized by cirrhosis-associated immune dysfunction (CAID). Our goal was to characterize the peritoneal immune landscape, focusing... ...
